Merit Medical Pumped By J&J Cypher Introduction, Shares Up 37% In July
This article was originally published in The Gray Sheet
Executive Summary
Merit Medical already has experienced 20% revenue growth for inflation devices related to increased cath lab activity, helping spur investor confidence in the firm's ability to cash in on the drug-eluting stent market